Literature DB >> 8252109

Peak bone mass, a growing problem?

E Seeman1, C Tsalamandris, C Formica.   

Abstract

The focus of attention in osteoporosis research has been on factors influencing bone fragility and the propensity for trauma (falls) during adulthood and old age. The purpose of this review is to change the focus of this attention toward consideration of skeletal growth in the first 20 years of life and to demonstrate the importance of mineral accrual (and the factors influencing this accrual) in determining bone density in adulthood and old age. We suggest that the epidemiology of fractures may be unified by a central role of reduced peak bone density in the pathogenesis of the low bone density found in patients with fractures. The reduced peak bone density establishes the relevance of age-related and sex hormone-dependent bone loss. Risk and protective factors in the first 20 years of life may have quantitatively larger, and qualitatively different effects on the axial and appendicular skeleton than exposure during adulthood. Public health measures focussed on optimising mineral accrual in the first 20 years of life may be more important than health care measures more proximate to the age at which fractures occur.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8252109

Source DB:  PubMed          Journal:  Int J Fertil Menopausal Stud        ISSN: 1069-3130


  3 in total

1.  Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study.

Authors:  K Casazza; L J Hanks; B Hidalgo; H H Hu; O Affuso
Journal:  Bone       Date:  2011-09-13       Impact factor: 4.398

Review 2.  The peak bone mass concept: is it still relevant?

Authors:  Eckhard Schönau
Journal:  Pediatr Nephrol       Date:  2004-06-09       Impact factor: 3.714

3.  Bone mineral density and blood metals in premenopausal women.

Authors:  A Z Pollack; S L Mumford; J Wactawski-Wende; E Yeung; P Mendola; D R Mattison; E F Schisterman
Journal:  Environ Res       Date:  2012-11-02       Impact factor: 6.498

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.